Skip to content
← Back to explorer

A deep learning pipeline for PAM50 subtype classification using histopathology images and multi-objective patch selection

Arezoo Borji, Gernot Kronreif, Bernhard Angermayr, Francisco Mario Calisto, Wolfgang Birkfellner, Inna Servetnyk, Yinyin Yuan, Sepideh Hatamikia · Apr 2, 2026 · Citations: 0

How to use this paper page

Coverage: Recent

Use this page to decide whether the paper is strong enough to influence an eval design. It summarizes the abstract plus available structured metadata. If the signal is thin, use it as background context and compare it against stronger hub pages before making protocol choices.

Best use

Background context only

Metadata: Recent

Trust level

Provisional

Signals: Recent

What still needs checking

Structured extraction is still processing; current fields are metadata-first.

Signal confidence unavailable

Abstract

Breast cancer is a highly heterogeneous disease with diverse molecular profiles. The PAM50 gene signature is widely recognized as a standard for classifying breast cancer into intrinsic subtypes, enabling more personalized treatment strategies. In this study, we introduce a novel optimization-driven deep learning framework that aims to reduce reliance on costly molecular assays by directly predicting PAM50 subtypes from H&E-stained whole-slide images (WSIs). Our method jointly optimizes patch informativeness, spatial diversity, uncertainty, and patch count by combining the non-dominated sorting genetic algorithm II (NSGA-II) with Monte Carlo dropout-based uncertainty estimation. The proposed method can identify a small but highly informative patch subset for classification. We used a ResNet18 backbone for feature extraction and a custom CNN head for classification. For evaluation, we used the internal TCGA-BRCA dataset as the training cohort and the external CPTAC-BRCA dataset as the test cohort. On the internal dataset, an F1-score of 0.8812 and an AUC of 0.9841 using 627 WSIs from the TCGA-BRCA cohort were achieved. The performance of the proposed approach on the external validation dataset showed an F1-score of 0.7952 and an AUC of 0.9512. These findings indicate that the proposed optimization-guided, uncertainty-aware patch selection can achieve high performance and improve the computational efficiency of histopathology-based PAM50 classification compared to existing methods, suggesting a scalable imaging-based replacement that has the potential to support clinical decision-making.

Use caution before copying this protocol

Use this page for context, then validate protocol choices against stronger HFEPX references before implementation decisions.

  • Structured extraction is still processing; current fields are metadata-first.

HFEPX Relevance Assessment

Signal extraction is still processing. This page currently shows metadata-first guidance until structured protocol fields are ready.

Best use

Background context only

Use if you need

A provisional background reference while structured extraction finishes.

Main weakness

Structured extraction is still processing; current fields are metadata-first.

Trust level

Provisional

Eval-Fit Score

Unavailable

Eval-fit score is unavailable until extraction completes.

Human Feedback Signal

Not explicit in abstract metadata

Evaluation Signal

Weak / implicit signal

HFEPX Fit

Provisional (processing)

Extraction confidence: Provisional

What This Page Found In The Paper

Each field below shows whether the signal looked explicit, partial, or missing in the available metadata. Use this to judge what is safe to trust directly and what still needs full-paper validation.

Human Feedback Types

provisional

None explicit

Confidence: Provisional Best-effort inference

No explicit feedback protocol extracted.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Evaluation Modes

provisional

Automatic metrics

Confidence: Provisional Best-effort inference

Includes extracted eval setup.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Quality Controls

provisional

Not reported

Confidence: Provisional Best-effort inference

No explicit QC controls found.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Benchmarks / Datasets

provisional

Not extracted

Confidence: Provisional Best-effort inference

No benchmark anchors detected.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Reported Metrics

provisional

F1

Confidence: Provisional Best-effort inference

Useful for evaluation criteria comparison.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Rater Population

provisional

Unknown

Confidence: Provisional Best-effort inference

Rater source not explicitly reported.

Evidence snippet: Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Human Data Lens

This page is using abstract-level cues only right now. Treat the signals below as provisional.

  • Potential human-data signal: No explicit human-data keywords detected.
  • Potential benchmark anchors: No benchmark names detected in abstract.
  • Abstract highlights: 3 key sentence(s) extracted below.

Evaluation Lens

Evaluation fields are inferred from the abstract only.

  • Potential evaluation modes: Automatic metrics
  • Potential metric signals: F1
  • Confidence: Provisional (metadata-only fallback).

Research Brief

Metadata summary

Breast cancer is a highly heterogeneous disease with diverse molecular profiles.

Based on abstract + metadata only. Check the source paper before making high-confidence protocol decisions.

Key Takeaways

  • Breast cancer is a highly heterogeneous disease with diverse molecular profiles.
  • The PAM50 gene signature is widely recognized as a standard for classifying breast cancer into intrinsic subtypes, enabling more personalized treatment strategies.
  • In this study, we introduce a novel optimization-driven deep learning framework that aims to reduce reliance on costly molecular assays by directly predicting PAM50 subtypes from H&E-stained whole-slide images (WSIs).

Researcher Actions

  • Compare this paper against nearby papers in the same arXiv category before using it for protocol decisions.
  • Validate inferred eval signals (Automatic metrics) against the full paper.
  • Use related-paper links to find stronger protocol-specific references.

Caveats

  • Generated from abstract + metadata only; no PDF parsing.
  • Signals below are heuristic and may miss details reported outside the abstract.

Recommended Queries

Related Papers

Papers are ranked by protocol overlap, extraction signal alignment, and semantic proximity.

No related papers found for this item yet.

Get Started

Join the #1 Platform for AI Training Talent

Where top AI builders and expert AI Trainers connect to build the future of AI.
Self-Service
Post a Job
Post your project and get a shortlist of qualified AI Trainers and Data Labelers. Hire and manage your team in the tools you already use.
Managed Service
For Large Projects
Done-for-You
We recruit, onboard, and manage a dedicated team inside your tools. End-to-end operations for large or complex projects.
For Freelancers
Join as an AI Trainer
Find AI training and data labeling projects across platforms, all in one place. One profile, one application process, more opportunities.